文献速递神经肌肉病

肌萎缩侧索硬化诊断与预后生物标志物:明确亚型中的神经丝轻链水平

Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease.
PubMed 文献 · JAMA Neurol · 2017-01-01

该单中心回顾性纵向研究纳入94例ALS、20例额颞叶痴呆、18例运动神经病和44例对照,发现ALS和FTD组脑脊液log[NFL]浓度高于运动神经病和对照组(HR 2.45,95%CI 1.66-3.61,P<.001),且log[NFL]与总生存呈负相关。上运动神经元受累和FTD患者NFL升高可能反映皮质脊髓束变性,而下运动神经元体征患者NFL低水平可能是较轻表型的预后指标。

要点

  • ALS和FTD患者脑脊液NFL浓度显著高于运动神经病和对照组。
  • 脑脊液log[NFL]浓度与ALS患者总生存呈负相关。
  • 上运动神经元受累和FTD患者NFL升高可能反映皮质脊髓束变性。

核心结论

  • 本研究证实NFL可作为ALS的生物标志物。
  • 上运动神经元受累和FTD患者NFL升高可能反映皮质脊髓束变性。
  • 下运动神经元体征患者NFL低水平可能是较轻表型的预后指标。

研究设计与样本

  • 单中心、回顾性、纵向研究,纳入176例患者脑脊液样本,于基线及6、12、24、36个月评估疾病进展。
  • 包括94例ALS、20例FTD、18例运动神经病和44例对照。

主要发现

  • ALS和FTD组log[NFL]浓度高于运动神经病和对照组(HR 2.45,95%CI 1.66-3.61,P<.001)。
  • 典型ALS(HR 1.0,参考)、进行性延髓麻痹(HR 1.48,95%CI 0.58-3.75,P=.41)和上运动神经元为主型ALS(HR 0.12,95%CI 0.02-0.61,P=.01)的NFL水平高于连枷臂或腿综合征(HR 0.28,95%CI 0.08-0.10,P=.049)和进行性肌萎缩(HR 0.17,95%CI 0.22-1.36,P=.10)。
  • log[NFL]浓度与总生存呈负相关(HR 2.45,95%CI 1.66-3.61,P<.001)。
  • 遗传性ALS中未见log[NFL]浓度和生存差异的证据。

临床怎么用

  • 脑脊液NFL可用于ALS的诊断辅助和预后评估。
  • 上运动神经元受累和FTD患者NFL升高提示皮质脊髓束变性。
  • 下运动神经元体征患者NFL低水平可能提示较轻表型。

局限性

  • 单中心回顾性研究,样本量有限。
  • 未报告遗传性ALS中NFL与生存的差异证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: A clearer definition of the role of neurofilament light chain (NFL) as a biomarker in amyotrophic lateral sclerosis (ALS) is needed. OBJECTIVES: To assess the ability of NFL to serve as a diagnostic biomarker in ALS and the prognostic value of cerebrospinal fluid NFL in patients with ALS. DESIGN, SETTING, AND PARTICIPANTS: In this single-center, retrospective, longitudinal study, disease progression was assessed by the ALS Functional Rating Score-Revised and the ALS Milano-Torino Staging system at baseline and 6, 12, 24, and 36 months. Cerebrospinal fluid samples were obtained from 176 patients admitted to the Department of Neurosciences of the University of Padua, Padova, Italy, from January 1, 2010, through February 29, 2016. Patients with ALS underwent ambulatory follow-up at the same department. MAIN OUTCOMES AND MEASURES: Levels of NFL. RESULTS: The study included 94 patients with ALS (64 men [36.4%] and 30 women [17.0%]; median age, 62.5 years), 20 patients with frontotemporal dementia (FTD) (8 men [4.5%] and 12 women [6.8%]; median age, 65 years), 18 patients with motor neuropathies (14 men [8.0%] and 4 women [2.3%]; median age, 63 years), and 44 controls (24 men [13.6%] and 20 women [11.4%]; median age, 54 years). Log-transformed NFL (log[NFL]) concentrations were higher in the ALS and FTD groups compared with the motor neuropathies and control groups (hazard ratio [HR], 2.45; 95% CI, 1.66-3.61; P < .001). Patients with typical ALS (HR, 1.0 [reference]), progressive bulbar palsy (HR, 1.48; 95% CI, 0.58-3.75; P = .41), and upper motor neuron dominant ALS (HR, 0.12; 95% CI, 0.02-0.61; P = .01) had higher levels of NFL than did those with flail arm or leg syndrome (HR, 0.28; 95% CI, 0.08-0.10; P = .049) and progressive muscular atrophy (HR, 0.17; 95% CI, 0.22-1.36; P = .10). There was an inverse correlation between log[NFL] concentration and overall survival (HR, 2.45; 95% CI, 1.66-3.61; P < .001). There was no evidence of different log[NFL] concentrations and survival in genetic ALS. CONCLUSIONS AND RELEVANCE: This study confirms the role of NFL as a biomarker in ALS. Elevation in NFL levels in patients with upper motor neuron involvement and FTD might reflect the corticospinal tract degeneration. Low NFL levels in patients with lower motor neuron signs might be a prognostic indicator of milder phenotypes of disease.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Gaiani A, Martinelli I, Bello L, et al. Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease. JAMA Neurol. 2017. PMID: 28264096. doi:10.1001/jamaneurol.2016.5398

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。